11-108271228-CTTTTT-CTTTTTT
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1
The NM_000051.4(ATM):c.2922-8dupT variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0307 in 1,516,430 control chromosomes in the GnomAD database, including 197 homozygotes. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_000051.4 splice_region, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ATM | NM_000051.4 | c.2922-8dupT | splice_region_variant, intron_variant | Intron 19 of 62 | ENST00000675843.1 | NP_000042.3 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0361 AC: 5148AN: 142408Hom.: 196 Cov.: 31
GnomAD4 exome AF: 0.0302 AC: 41443AN: 1373970Hom.: 1 Cov.: 0 AF XY: 0.0280 AC XY: 19204AN XY: 685824
GnomAD4 genome AF: 0.0362 AC: 5156AN: 142460Hom.: 196 Cov.: 31 AF XY: 0.0368 AC XY: 2544AN XY: 69172
ClinVar
Submissions by phenotype
not specified Benign:5
Variant summary: ATM c.2922-8dupT alters a nucleotide located close to a canonical splice site. The variant allele was found at a frequency of 0.047 in 186328 control chromosomes, predominantly at a frequency of 0.17 within the Latino subpopulation in the gnomAD database, including 2 homozygotes. The observed variant frequency within Latino control individuals in the gnomAD database is approximately 43.007 fold of the estimated maximal expected allele frequency for a pathogenic variant in ATM causing Ataxia-Telangiectasia phenotype (0.004), strongly suggesting that the variant is a benign polymorphism found primarily in populations of Latino origin. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as benign. -
- -
- -
This variant is classified as Benign based on local population frequency. This variant was detected in 22% of patients studied by a panel of primary immunodeficiencies. Number of patients: 21. Only high quality variants are reported. -
- -
not provided Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at